Neo HCG 5000 iu Injection (HCG)
Price range: 45.00$ through 130.00$
Product Overview Neo HCG 5000 IU Injection is a prescription medication formulated to address female infertility. Produced by Neon Laboratories, the product delivers 5000 International Units (IU) of Human Chorionic Gonadotropin (HCG) per vial. Each p
| Active Ingredients | HCG (Human Chorionic Gonadotropin) |
|---|---|
| Delivery Time | 6 To 15 days |
| Indication | female infertility |
| Manufacturer | Neon Laboratories |
| Packaging | 1 Vial in Box + 1 NacL Amp. |
| Strength | 5000iu |
Product Overview
Neo HCG 5000 IU Injection is a prescription medication formulated to address female infertility. Produced by Neon Laboratories, the product delivers 5000 International Units (IU) of Human Chorionic Gonadotropin (HCG) per vial. Each package contains a single vial of lyophilized hormone together with a sterile water ampoule for reconstitution. The medication is supplied in three pack configurations: one injection, three injections, or six injections per box. Neo HCG is indicated for stimulating ovarian function, supporting ovulation, and enhancing the chances of conception in assisted reproductive procedures. The formulation complies with pharmaceutical standards and is distributed with a recommended storage temperature of 2‑8°C until use.
What is Neo HCG 5000 IU Injection
Neo HCG 5000 IU Injection belongs to a class of gonadotropins that mimic the action of the endogenous hormone chorionic gonadotropin. After reconstitution, the solution provides a potent stimulus for the luteinizing hormone (LH) receptors present on ovarian granulosa cells, leading to the final maturation of oocytes. The drug is derived from a purified preparation of human chorionic placenta and is standardized to contain exactly 5000 IU of biologically active HCG per vial. This dosage is commonly employed in controlled ovarian stimulation protocols, where precise hormonal dosing is essential for optimizing egg yield while minimizing the risk of ovarian hyperstimulation syndrome.
Uses and Benefits
Clinically, Neo HCG 5000 IU Injection is utilized in several fertility treatment pathways. In ovulation induction, it is administered to trigger the LH surge that prompts the release of mature eggs from dominant follicles. During in‑vitro fertilization (IVF) cycles, the hormone supports the luteal phase after egg retrieval, improving endometrial receptivity and implantation rates. Additional benefits include the ability to synchronize follicular development, reduce the need for exogenous LH supplements, and enable flexible scheduling of oocyte pickup procedures. According to research from the National Institutes of Health, HCG therapy has been shown to increase live birth rates in specific patient cohorts. Because the medication is supplied in pre‑measured doses, clinicians can tailor treatment regimens to individual patient response, thereby optimizing success percentages while maintaining cost‑effectiveness.
How It Works
The mechanism of action of Neo HCG 5000 IU Injection involves binding to LH receptors on ovarian cells, which mimics the natural LH peak that follows follicular maturation. This binding activates intracellular signaling pathways that stimulate the production of cyclic adenosine monophosphate (cAMP), leading to the synthesis of progesterone and the finalization of oocyte maturation. In the context of assisted reproduction, the exogenous hormone provides a controlled surge that can be timed precisely with ultrasound monitoring, ensuring that the eggs are harvested at the optimal developmental stage. The predictable pharmacodynamics of HCG allow physicians to achieve consistent ovulation rates across patient populations.
Dosage Guidelines
Dosage of Neo HCG 5000 IU Injection must be individualized according to the patient’s ovarian reserve, response to prior stimulation, and the specific protocol employed by the treating physician. Typical regimens involve a single intramuscular or subcutaneous administration of one vial (5000 IU) after ultrasound confirmation of follicular maturity, usually when follicles reach a mean diameter of 18‑20 mm. In some protocols, a split dose of 2500 IU may be given 12‑24 hours before the planned oocyte retrieval to fine‑tune the LH surge. Patients are advised to follow the exact reconstitution instructions, to use sterile technique, and to store the reconstituted solution at room temperature for no longer than 12 hours. Regular monitoring of serum estradiol levels and follicular dimensions guides any dose adjustments. For more detailed dosing information, refer to the Drugs.com database.
Side Effects
Like all hormonal medications, Neo HCG 5000 IU Injection can be associated with adverse effects, although many are mild and transient. Common side effects include injection site pain or irritation, headache, mild abdominal discomfort, and brief episodes of nausea. Less frequently, patients may experience ovarian hyperstimulation syndrome (OHSS), characterized by rapid weight gain, abdominal distension, and decreased urine output; in such cases, medical attention should be sought promptly. Rarely, allergic reactions ranging from rash to anaphylaxis have been reported. For an extensive list of reported reactions, consult Drugs.com. It is important for clinicians to counsel patients about the signs of OHSS and to provide emergency contact information for severe symptoms.
Warnings and Precautions
Neo HCG 5000 IU Injection is contraindicated in individuals with known hypersensitivity to HCG or any of the excipients, as well as in patients with active ovarian cysts unrelated to treatment, certain types of tumors, or thromboembolic disorders. Prior to initiation, a thorough medical history should be obtained to identify conditions such as pituitary adenoma, thyroid disease, or unexplained vaginal bleeding. The medication should not be used in pregnant women unless specifically indicated for therapeutic termination, and it must be discontinued if pregnancy is confirmed. Clinicians are advised to screen for underlying reproductive cancers and to discuss the potential for multiple gestations, which can increase maternal and fetal risks. The U.S. Food and Drug Administration provides guidance on hormonal medications. Proper storage at 2‑8 °C and adherence to expiration dates are essential to preserve potency.
FAQs
Question: What is the recommended storage condition for Neo HCG 5000 IU Injection?
Answer: The medication should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen. Once reconstituted, the solution can remain at room temperature (up to 25 °C) for no more than 12 hours; any unused portion should be discarded after this period.
Question: How is the medication reconstituted before use?
Answer: To reconstitute, withdraw the sterile water from the ampoule, inject it slowly into the vial, and gently swirl until the powder dissolves completely. Do not shake vigorously, as this may degrade the hormone. The clear solution should be inspected for particles before administration.
Question: Can Neo HCG be used for male infertility?
Answer: Although HCG is primarily indicated for female fertility, it is also used off‑label in male fertility treatments to stimulate testosterone production. However, its use in men must be prescribed by a qualified healthcare provider and is not covered by the current product labeling for female infertility.
Question: What should I do if I miss a scheduled dose?
Answer: If a dose is missed, patients should contact their clinician before attempting to administer the medication. Re‑dosing may be unsafe, especially if the timing of ovulation trigger is critical. The physician may adjust the schedule or suggest an alternative protocol.
Question: Are there any drug interactions I should be aware of?
Answer: Neo HCG may interact with medications that affect hormone levels, such as certain GnRH agonists, anti‑estrogens, or anticoagulants. Patients should disclose all prescription, over‑the‑counter, and herbal products to their doctor to assess potential interactions.
Related Products
- Adrenaline / Epinephrine (Generic)
- Vasocon Injection (Adrenaline (Epinephrine))
- Vanking 1000 Infusion (Vancomycin)
- Vancomycin 1000 Infusion (Generic)
- Lidocaine Heavy Injection (Generic)
- Lox Heavy Injection (Lidocaine)
- Prilox Cream 30g (Prilocaine/Lidocaine )
- Prilox Cream 5g (Prilocaine/Lidocaine)
- ZyhCG 10000 (HCG 10000iu)
- ZyhCG 5000 (HCG 5000iu)
- ZyhCG 2000 (HCG 2000iu)
- Sifasi Aqua 5000 (HCG (Human Chorionic Gonadotropin))
Related Products
Product Overview Clomiphene 25 mg is a generic pharmaceutical formulation that contains the selective estrogen receptor modulator clomiphene citrate as the active ingredient. Manufactured by Serum Institute India, this medication is indicated for the
In stock
Product Overview hMG 150iu Injection, marketed under the brand name Menotrophin, is a pharmaceutical preparation supplied by Sanzyme Biologics (P) Ltd. The product is indicated for the treatment of female infertility, male hypogonadism, and male infe
In stock
Product Overview Gestobond 400 mg is a pharmaceutical preparation containing progesterone, a synthetic analogue of the natural hormone essential for regulating the menstrual cycle and supporting early pregnancy. Manufactured by Gufic Biosciences Ltd.
In stock
Product Overview
hCG 10000iu Injection, manufactured by Sanzyme Biologics (P) Ltd, is a lyophilized preparation of human chorionic gonadotropin supplied in a 1 ml sealed vial. The product is delivered as a sterile powder that must be reconstituted
In stock
Neo HCG 10000 iu Injection (HCG) – Product Overview
Neo HCG 10000 iu Injection, produced by Neon Laboratories, is a pharmaceutical preparation that contains human chorionic gonadotropin (HCG) at a strength of 10,000 international units per vial. Th
In stock
n Product Overview n Progesterone 200 mg Injection is a sterile, aqueous solution formulated for intramuscular or subcutaneous administration. Each ampule or vial delivers a precise 200 mg dose of micronized progesterone, a natural steroid hormone
In stock
Product Overview Progesterone 50 mg injection is a sterile, ready‑to‑use formulation supplied by Sanzyme Biologics (P) Ltd. Each vial contains 1 ml of 50 mg progesterone in a clear glass ampoule. The product is indicated for female infertility and ho
In stock
Product Overview
Finast 5mg is a pharmaceutical tablet manufactured by Dr Reddy’s Laboratories Ltd. Each strip contains 30 film‑coated tablets that deliver a precise 5 mg dose of finasteride, a synthetic 4‑azasteroid compound. The product is formul
In stock
Product Overview
Progesterone 300 mg is a pharmaceutical-grade oral capsule formulated to support women experiencing hormonal imbalances related to female infertility and menopausal symptoms. Manufactured by Sun Pharmaceutical Industries Ltd, each
In stock
Product Overview Clomiphene 100 mg represents a generic pharmaceutical formulation that has become a cornerstone in the management of female infertility, particularly among women diagnosed with ovulatory dysfunction such as polycystic ovary syndrome
In stock
Product Overview
Menotropin HMG 150iu Injection, supplied by German Remedies Private Ltd, is a standardized preparation of human menopausal gonadotropin (HMG) indicated for the management of female infertility associated with anovulation or oligo‑o
In stock
Product Overview
Susten SR 400 mg is a sustained‑release tablet formulated by Sun Pharmaceutical Industries Ltd. It delivers a controlled dose of progesterone, a key steroid hormone involved in regulating the menstrual cycle and supporting early pr
In stock
Reviews
There are no reviews yet.